As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The future of the weight loss market might not revolve around GLP-1 drugs.
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
In the ever-changing healthcare landscape, it is crucial to develop sustainable long-term strategies that look beyond ...
In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...
Surging demand for weight loss drugs Wegovy and Zepbound from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) has fueled concerns ...
A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
"Their effects on vaginal health are an important consideration that is often overlooked," gynecologist Melanie Bone told Newsweek.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Thieves broke into a South Fulton pharmacy early Thursday morning, stealing thousands of dollars in medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback